
CAS: 1223405-08-0
Sort by
Found 5 products.
Larotrectinib sulfate
CAS:Larotrectinib sulfate (LOXO-101 sulfate) is an oral active and specific ATP-competitive inhibitor of tropomyosin receptor kinases (TRK).Formula:C21H22F2N6O2·H2O4SPurity:98.62% - 99.69%Color and Shape:SolidMolecular weight:526.51Ref: TM-T6880
2mg39.00€5mg57.00€10mg93.00€25mg131.00€50mg163.00€100mg274.00€500mg658.00€1mL*10mM (DMSO)66.00€Larotrectinib Sulfate
CAS:Controlled ProductApplications Larotrectinib Sulfate is a potent and selective oral ATP-competitive inhibitor of tropomyosin receptor kinases (TRK). References Anon.: Cancer Discovery, 6, 4 (2016); Passiglia, F., et al.: Expert Opin. Investig. Drugs, 25, 385 (2016)Formula:C21H22F2N6O2·(H2O4S)Color and Shape:NeatMolecular weight:428.44 + (98.08)1-Pyrrolidinecarboxamide, N-[5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3S)-, sulfate (1:1)
CAS:Formula:C21H24F2N6O6SPurity:98%Color and Shape:SolidMolecular weight:526.5137Larotrectinib sulphate
CAS:A potent ATP-competitive inhibitor of tropomyosin-related kinases (TRK1, TRK2 and TRK3), members of the receptor tyrosine kinase family of neurotrophin receptors. Tumors with oncogenic TRK fusions are sensitive to larotrectinib, leading to reduced proliferation and tumor growth in patients with soft tissue sarcoma, triple-negative breast cancer and lung cancer.Formula:C21H22F2N6O2H2SO4Purity:Min. 95%Molecular weight:526.51 g/mol